Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More
Designer Brands Inc. (NYSE: DBI) was named as the Zacks Bear of the Day stock. The firm said that due to slowing comps and recent acquisitions, this footwear retailer is stumbling. Shares last closed at $15.60, with a consensus price target of $18.14.
Dominion Energy Inc. (NYSE: D) was reiterated as Buy and the target price was raised to $87 from $83 at Argus. The independent research firm talked up its continued growth opportunities from its new liquefied natural gas storage plant and others.
FedEx Corp. (NYSE: FDX) was downgraded to Hold from Buy at Argus, with the firm noting that sales are declining while margins are compressing.
Insight Enterprises Inc. (NASDAQ: NSIT) was named as the Bull of the Day at Zacks, which said that this tech retailer has shown healthy growth across all of its major regions. Shares most recently closed at $69.20 and have a consensus price target of $70.00.
Nike Inc. (NYSE: NKE) was reiterated as Buy and its target price was raised to $115 from $105 at Argus, which expects it to trade up toward the high-end of its five-year valuation range, based on continued strength in the United States and China.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was started as Market Perform at Raymond James.
Sarepta Therapeutics Inc. (NASDAQ: SRPT) was maintained as Outperform at Credit Suisse, but the firm trimmed its target price to $185 from $190 in the call. Morgan Stanley reiterated its Overweight rating and raised its target to $173 from $160. The stock closed up 7.5% at $135.58 on Monday, and its consensus target price was $196.95.
Y-mAbs Therapeutics Inc. (NASDAQ: YMAB) was started with an Overweight rating and a $39 target price at JPMorgan. It closed up 2.1% at $32.42 ahead of this call, and its consensus target price was $38.43.
These are the top biopharma events to watch on the calendar heading into 2020.
Here is a review of which defense stocks look cheap and which do not heading into 2020.
RBC has issued three top hardlines retailers it sees as top picks for very strong gains in 2020, but the firm has a half-dozen or so runners-up as well that it would love investors to buy on pullbacks.
Three Credit Suisse #1 Top Picks have Outperform ratings and are called to rise 50% or more in 2020.
Five gold stocks are set to deliver upside performance on top of the stock market in 2020.
These are the seven most undervalued Dow stocks for gains and dividends heading into 2020.
Goldman Sachs has three top health care picks to outperform in 2020.